key: cord-0795114-xlz82zma authors: Sharov, Konstantin S. title: HIV/SARS-CoV-2 co-infection: T cell profile, cytokine dynamics and role of exhausted lymphocytes date: 2020-10-25 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2020.10.049 sha: 9c1035fe92ee6d9ca5c65a5d94ee1e4a400f3a71 doc_id: 795114 cord_uid: xlz82zma OBJECTIVES: The aim was to investigate if there is a synergy in HIV and COVID-19 in their influence upon human immunity; if there is an exacerbation of HIV patients’ immune status by SARS-CoV-2; and if HIV without ART leads to a more serious COVID-19 course than HIV with a proper antiretroviral therapy (ART). DESIGN: The anonymised blood samplings and clinical data were collected in 47 hospitals, clinics and medical centres in six Russian cities/regions in time range 20 March – 15 June 2020. 376 HIV/COVID-19 patients were studied (171 without ART and 205 with ART). Control group was represented by 382 SARS-CoV-2-positive persons without HIV. Lymphocyte and cytokine amounts were measured by flow cytometry and ELISA. The work is a retrospective study. RESULTS: COVID-19 led to rapid augmenting the process of T-cell exhaustion initially caused by HIV and this T cell degradation was most pronounced in patients without ART. A rise in IL-10 and TGFβ serum concentrations was observed. Diminishing CD4(+)/CD8(+) and Th1/Th2 ratios characteristic for HIV progression was accompanied by a surge in exhausted T-cell count with simultaneous exacerbating COVID-19-related respiratory distress. CONCLUSIONS: HIV without ART may be a very serious comorbidity of COVID-19 whereas immunity of HIV/COVID-19 patients with a proper ART is not generally affected by SARS-CoV-2. HIV-1 and SARS-CoV-2 are likely to exhibit a synergic effect and exhausted T-lymphocyte dynamics may be its effective marker. HIV-1 and SARS-CoV-2 co-action in human beings is a matter of growing research interest and clinical importance, including the problem of searching for a most appropriate and relevant therapy (Calza et al., 2020; Härter et al., 2020; Mascolo et al., 2020) . Both diseases are global pandemics (Patel et al., 2020) . As Wolfgang Sassin notes, the worldwide spread of both diseases is truly global and it is a direct consequence of digital-age globalisation with huge level of crossborder people relocation, tourist flows and migration on a scale of the entire planet without any cultural, religious, national, racial, mental and other boundaries (Sassin, 2019a; 2019b; . The character of the simultaneous effect of these two diseases on people mainly concerns possible deterioration of human immune system (Neidleman et al., 2020; Silva-Arrieta et al., 2020) . (Pinnetti et al., 2020; Schmidt et al., 2020; Shah et al., 2020) . However, there is a contradictory viewpoint. In International Journal of Infectious Diseases, Wang et al. have recently reported a case of one HIV/COVID-19 patient with low CD4 + count who had a longer COVID-19 course and lower antibody amount (Wang et al., 2020) . Further, it has been detected that HIV/SARS-CoV-2 co-infection may lead to pneumonia complications oftener than COVID-19 itself (Madge et al., 2020; Okoh et al., 2020) . The ability of HIV/SARS-CoV-2 co-infection to cause excessive T cell activation has been observed in sample sets little in size (D'Ettorre et al., 2020; Gao et al., 2020) . Besides, it has been detected that COVID-19 severe symptomatic manifestations may lead to a more pronounced T cell response than mild symptomatic clinical course (Ho et al., 2020; Mondi et al., 2020) . In the current work, we report T cell profile as well as levels and lymphocytic producing ability for a number of cytokines involved in T cell regulation of two groups of PLWH tested positive for SARS-CoV-2, with a proper antiretroviral therapy (ART) and without it, as well as control group of SARS-CoV-2-positive persons without HIV. The major purpose of the study was to find out on the basis of the T cell counts and cytokine amounts / production detected: 1) if there is a synergy in HIV and COVID-19 in their influence upon human immunity; 2) if there is an exacerbation of HIV patients' immune status by SARS-CoV-2; and 3) if HIV without ART leads to a more serious COVID-19 course than HIV with a proper ART. J o u r n a l P r e -p r o o f (without ART, 171 cases, 22-67 years) and Group 2 (with ART, 205 cases, 18-58 years). Antiretroviral therapy (ART) was suspended during COVID-19 pandemic due to antiretroviral medication shortages in Group 1 (ART interruption of 1.5-6.5 months with the median 3.5 months), and properly continued in Group 2. Group 3 (control group) was represented by 382 SARS-CoV-2-positive persons without HIV. Composition of Group 3 was carried out in such a way to match demographics (age, gender, social strata, habits) and clinical data (comorbidities, COVID-19 severity) of Group 1 + Group 2 as closely as possible. No asymptomatic SARS-CoV-2 carriers were considered in the current research. The information was collected in 47 hospitals, clinics and medical centres in six Russian regions studied in the current research (Moscow, Moscow region, St Petersburg, Nizhny Novgorod, Murmansk, Krasnodar). The number of PLWH positive for SARS-CoV-2 and residing in the six aforementioned Russian regions, can be estimated as some 3,000-3,500 persons. This figure can be obtained by multiplying official statistics of PLWH in these regions published by Russian Statistical Agency (Rosstat) by average population infection rate measured by us for these regions. Such a methodology has some deficiencies. First, we assume that population infection rate in PLWH group is the same as in general population, but that can be an incorrect or not always correct premise. Second, official governmental statistics does not count results of anonymised positive HIV tests, as according to Russian law, medical centres and clinics have a right not to disclose such results made on an anonymous basis. However, despite the flaws J o u r n a l P r e -p r o o f described, such simple approach allows one to estimate the overall number of PLWH in different geographical regions in Russia, at least roughly. The work was carried out in 20 March -15 June 2020 range. Reporting of the study conforms to broad EQUATOR and STROBE-NI cohort studies guidelines. No identifying information was accompanying clinical data. In hospitals, government-sponsored medical centres and private clinics involved in treating the patients or surveillance, a written informed consent has been taken from every patient/carrier concerned that he/she gives a clear permission to use their anonymised data for scientific research and publications. All written informed consents duly signed are located in the hospitals, clinics, and medical centres. Ethical Committee of Koltzov Institute of Developmental Biology of Russian Academy of Sciences gave its approval for the conduct of the study (protocol no. 39100920). The study was not a randomised controlled clinical trial. Immune status detection and other relevant measurements were performed retrospectively. Respiratory score J o u r n a l P r e -p r o o f Usually, PaO2 / FiO2 ratio is used as an indicator of respiratory distress. We observed that using an overall respiratory score (RS) instead of it may give a better result, since RS also concerns respiratory frequency (respiratory rate) and SpO2 besides PaO2 / FiO2 ratio. OriginLab Origin 8.1 Pro was used for statistical calculations and visualisation. T cell response . A negligibly small level of T cell exhaustion was detected for Group 3. In Figure 1 , panel E, we may observe that severe COVID-19 cases with pronounced respiratory distress (high values of respiratory score RS whose detailed description is provided in Methods section) are also associated with high level of T lymphocyte exhaustion. In Figure 1 , panel F, one can see that Th1/Th2 ratio shrinks in Group 1 (left column) during COVID-19 course along with diminishing CD4 + /CD8 + ratio. It remains lower after COVID-19 than before the disease, while for Groups 2 and 3 there is no such tendency. Besides, we can also J o u r n a l P r e -p r o o f discern from Figure 1 , panel F, that T helper activation from CD4 + naive lymphocytes and proliferation are much more effective for PLWH with ART, to say nothing of people without HIV, in comparison with patients of Group 1. The results of cytokine dynamics study are presented in Figure 2 . IL-2, TNFα, IFNγ, IL-10 and TGFβ1 cytokines were investigated that are deemed to be closely connected with PLWH immunity degradation (Pett et al., 2010; Rich et al., 2019; Yarilin, 2010) . We revealed that SARS-CoV-2 might exacerbate the process of T cell exhaustion in decreasing Table 2 . J o u r n a l P r e -p r o o f Exhausted T cells are known to lose their ability to produce IL-2, TNFα, IFNγ during the process of their exhaustion. At first, T cells stop to synthesise IL-2, then TNFα and finally IFNγ (Blank et al., 2019; Wherry, 2011) . Our results indicate that HIV/SARS-CoV-2 co-infection augments the process of T cell exhaustion. Figure and 2 with maximums around four weeks since the COVID-19 onset (Figure 2 , panels E-F), may have strengthened T cell exhaustion further. IL-10 and TGFβ serum amounts have been reported to be higher in PLWH than in general population (D'Ettorre et al., 2020; Ho et al., 2020; Yarilin, 2010) . In our study, we observed as well higher pre-COVID amounts of the two cytokines in question as their more pronounced growth during COVID-19 course in Group 1 than in Group 2 or especially Group 3 (Figure 2 , panels E-F). That may indicate a weaker immune response to SARS-CoV-2 acute infection in patients of Group 1 than of Group 2 or Group 3. IL-10 and TGFβ time dynamics was well correlated, with Pearson correlation coefficient being 0.8835 at p = 0.008349. Our study proves that HIV without ART can be a dangerous comorbidity of COVID-19, while PLWH with ART do not generally suffer from additional immunity deterioration that may be associated with SARS-CoV-2. Studying thirty HIV/SARS-CoV-2 co-infected patients, a research team from Bichat-Claude Bernard University Hospital (Paris, France) has deduced of late that HIV infection is probably not an independent risk factor for COVID-19 (Isernia et al., 2020) . We support their view strongly, with the proviso that HIV is virologically suppressed with a proper ART, HIV viral load in serum is less than 50 copies/ml and CD4 + lymphocyte count higher than 500 1/μl. Indeed, in such a patient, as we observed in our own investigation, HIV does not represent a serious COVID-19 comorbidity statistically, whereas SARS-CoV-2 does not influence immunity of J o u r n a l P r e -p r o o f such a patient more than immunity of general population. However, if ART interruption lasts for two-three months and especially six months and more, HIV may become a very dangerous risk factor for COVID-19 clinical course and outcome. Therefore, providing a proper ART to PLWH during the COVID-19 pandemic is crucial for medical systems around the world (Nakamoto et al., 2020; Patel et al., 2020; Sharov, 2020a; 2020b) . The healthcare systems must be sustained by governmental actions aimed at prevention of pharmaceutical supply chain disruptions, as in the situation of truly global society such disruptions may bring on tremendous harm to the world population (Donskikh, 2019; Etienne et al., 2020; Guo et al., 2020; Lysenko, 2019; Moskovkin, 2020) . HIV-1 and SARS-CoV-2 are likely to exhibit a synergic effect. The levels and time dynamics of 1) exhausted T lymphocyte count in serum; 2) IL-2, TNFα and IFNγ serum amounts; 3) IL-2, TNFα and IFNγ lymphocytic producing capability; and 4) IL-10 and TGFβ serum amounts during COVID-19 course may be an effective complex prognostic marker of this synergy. Miloslavskaya, Anton Panin, Yulia Smirnova, Maxim Tsarkov for their provision of clinical data. Funding: This work has been funded by Government program of basic research in Koltzov Institute of Developmental Biology, Russian Academy of Sciences in 2020, No. 0108-2019-0002. The authors have no conflicts of interest to declare. Russian Academy of Sciences regarded the current study ethically appropriate and exempt from human subjects review, as no clinical trials were performed, the authors were not personally involved in collecting the clinical data and hence do not possess any information that might identify the patients. In hospitals and clinics involved in treating the patients, a written informed consent has been taken from every patient concerned that he/she gives a clear permission to use their data for scientific research and publications. All written informed consents duly signed are kept in the hospitals, clinics, ambulance and medical centres. Defining 'T cell exhaustion COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report Horror Zivilisationis, oder Horror der Subjektivität HIV infection and COVID-19: risk factors for severe disease Predicting the Immunogenicity of T cell epitopes: From HIV to SARS-CoV-2 Driving Force of Covid-19 Among People Living With HIV/AIDS in Wuhan COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients Covid-19 in people with HIV SARS-COV2 infection in 30 HIV-infected patients followedup in a French University Hospital Back to anthropology: What does it mean to development studies? Descriptive account of 18 adults with known HIV infection hospitalised with SARS-CoV-2 infection Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2 Do We Need a Great Reset? COVID-19, Black Revolution, Inequality and Common Good A case of SARS-CoV-2 infection in an untreated HIV patient in SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential COVID-19 Pneumonia in Patients With HIV: A Case Series COVID-19 and AIDS: Outcomes from the coexistence of two global pandemics and the importance of chronic antiretroviral therapy Role of interleukin-2 in patients with HIV infection SARS-CoV-2 infection does not induce HIV viral escape in Central Nervous System: a case series Die Grenzen der Ökonomie: Globalisierung -Vom Füllhorn zum Giftbecher? Er-Schöpfung der Schöpfung, oder Eine neue Kulturstufe in der Entwicklung des homo Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past COVID-19 pandemic: A survival challenge to humanity unseen thus far or a déjà vu experience? Creating and applying SIR modified compartmental model for calculation of COVID-19 lockdown efficiency In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4(+) T-cell count T cell exhaustion